Intended for healthcare professionals

  1. News & Views
  2. FDA allows drugs...
News Exclusive Investigation

FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway

BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1898 (Published 30 July 2021) Cite this as: BMJ 2021;374:n1898

FDA accelerated drug approval

Your browser does not support the canvas tag.
Please note, infographics are currently only supported on desktop/laptop machines, so you may not be able to view them properly on your device.

Display infographic